Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report
Anti-N-methyl D-aspartate (NMDA) receptor (anti-NMDAR) encephalitis has been reported after SARS-CoV-2 infection, but not after SARS-CoV-2 vaccination. We report the first known case of anti-NMDAR encephalitis after SARS-CoV-2 immunization in a young female presenting with acute psychosis, highlight...
Guardado en:
Autores principales: | Patrick Flannery, Ingrid Yang, Madjid Keyvani, George Sakoulas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/975cc603cd7e4ce38dc2a638260992ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review
por: Wang HY, et al.
Publicado: (2019) -
A peculiar case of psychosis: anti-NMDAr encephalitis
por: Lamia Kouba, et al.
Publicado: (2021) -
N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection
por: Tsutsui K, et al.
Publicado: (2017) -
Early multidisciplinary intensive-care therapy can improve outcome of severe anti-NMDA-receptor encephalitis presenting with extreme delta brush
por: Schneider R., et al.
Publicado: (2019) -
Anti-NMDA-receptor encephalitis: an unusual treatable cause of chronic insomnia?
por: Wietse A. Wiels, et al.
Publicado: (2021)